Furthermore, a plethora of studies showed that the PTEN/AKT/mTOR or BDNF/synaptophysin pathway was not changed in a variety of depression models compared to that of the control group (Ju et al., 2022; Olave et al., 2022; Yang et al., 2022). Here, AKT1 is linked to depressive symptom measurement.